Skip to content
RecallWatchMedical Device Safety
Class IIOngoingZ-2321-2026

Fresenius Medical Care Holdings, Inc. recalls Bicarby" Dialysate

Fresenius Medical Care Holdings, Inc.Waltham, MA, United StatesReported Jun 17, 2026 · 1 month ago
Legal News Analyst ·

Reason for recall

Given the increased number of leaks reported by users, it was determined to be the appropriate course of action to notify users of the potential for the occurrence of Bicarby luer-lock leaks during manipulation of the frangible and tubing when preparing the product for use for treatment. This issue presents the potential of a slip and fall hazard associated with fluid on the floor.

Affected product

Check your device

Enter a lot, serial, REF, or UDI number from your device's label to check it against this recall's listed codes.

Bicarby" Dialysate; Model Numbers: RFP-400-G, RFP-401-G, RFP-402-G, RFP-404-G, RFP-407-G, and RFP-456-G;

Lot / code information

Model
RFP-400-G
UDI
00840861102839; 2
Model
RFP-401-G
UDI
00840861102853; 3
Model
RFP-402-G
UDI
00840861102822; 4
Model
RFP-404-G
UDI
00840861102914; 5
Model
RFP-407-G
UDI
00840861102846: 6
Show 3 more code fields
Model
RFP-456-G
UDI
00840861102945; All lots produced from January 13, 2025, through
Lot #
26AG02019 on January 13, 2026

What the firm is doing

On 5/12/2026 an IMPORTANT MEDICAL DEVICE INFORMATION letters were sent to customers to inform them that manipulation of the luer-lock location during treatment preparation may result in fluid spillage onto the user and floor. This occurs prior to treatment and renders the product unusable. Direct contact with the fluid does not present any risk to the user as frangible manipulation only occurs after the peal seam has been broken and the two fluid compartments have been mixed. The potential risk associated with the affected Bicarby Dialysate product is a slip and fall hazard due to the presence of fluid on the floor.

DistributionShow details

US Nationwide distribution in the states of NY, TN and TX.

Class IIWhat this means

Use of the product may cause temporary or medically reversible adverse health consequences.

Sources & references

Taylor Coteus
Legal News Analyst

Taylor Coteus is RecallWatch's Legal News Analyst, covering FDA medical-device enforcement and patient-safety litigation. He reviews every recall against the FDA's official openFDA record before it is published and is responsible for corrections and editorial accuracy.

More Class II recalls